Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.700
-0.040 (-0.84%)
At close: Jun 27, 2025, 4:00 PM
4.750
+0.050 (1.06%)
After-hours: Jun 27, 2025, 7:46 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $752.73 million as of June 27, 2025. Its market cap has increased by 118.85% in one year.
Market Cap
752.73M
Enterprise Value
963.04M
1-Year Change
118.85%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $752.73M, an increase of 154.49%. That is a compound annual growth rate of 28.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 759.13M | 50.21% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |